微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1.97% | 126.44% | -6.64% | 52/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | 2.11% | 148.24% | -14.23% | 86/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | 2.46% | 67.35% | 45.56% | 89/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | 1.69% | 46.96% | 94.25% | 84/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | 0.87% | 24.29% | 2.35% | 88/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | 0.85% | 121.04% | -42.18% | 98/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | 1.47% | 1236.36% | 27.83% | 102/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | 1.15% | 2016.67% | 64.29% | 100/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | 0.7% | -1.41% | 117.33% | 101/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | -4.04% | -178.62% | -3772.73% | 114/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | 0.11% | -96.36% | 283.33% | 114/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | -0.06% | -106.82% | -108.45% | 114/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | 0.71% | -66.03% | 148.97% | 101/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | -1.45% | -127.67% | -148.01% | 110/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | 3.02% | -57.94% | 243.18% | 84/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | 0.88% | -85.28% | -57.89% | 104/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | 2.09% | -26.92% | -60.11% | 55/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | 5.24% | -47.49% | -27.02% | 77/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 7.18% | -32.01% | 20.07% | 59/157 | 4.46% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | 5.98% | 15% | 109.09% | 39/157 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2021-03-31 | 2.86% | 56.28% | -71.34% | 44/157 | 2.49% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 9.98% | -20.98% | -5.49% | 54/157 | 3.8% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | 10.56% | -20.24% | 103.08% | 34/157 | 3.13% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 5.2% | -37.87% | 184.15% | 54/157 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | 1.83% | -44.71% | -85.51% | 51/157 | 2.23% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | 12.63% | 6.22% | -4.61% | 38/157 | 2.57% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-09-30 | 13.24% | 18% | 58.18% | 16/157 | 7.58% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 8.37% | 18.89% | 152.87% | 24/157 | 5.02% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | 3.31% | 24.91% | -72.16% | 31/157 | 2.45% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 11.89% | 12.28% | 5.97% | 41/157 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2018-09-30 | 11.22% | 2.37% | 59.38% | 18/157 | 7.21% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 7.04% | -7.12% | 165.66% | 23/157 | 4.63% | 奥赛康 | 40.69% | 行业排名> |
| 2018-03-31 | 2.65% | -8.3% | -74.98% | 38/157 | 2.57% | 信立泰 | 25.93% | 行业排名> |
| 2017-12-31 | 10.59% | 12.06% | -3.38% | 45/157 | 9.62% | 昂利康 | 15.91% | 行业排名> |
| 2017-09-30 | 10.96% | 30.32% | 44.59% | 22/157 | 8.31% | 奥赛康 | 12.08% | 行业排名> |
| 2017-06-30 | 7.58% | 25.7% | 162.28% | 22/157 | 5.56% | 一品红 | 31.62% | 行业排名> |
| 2017-03-31 | 2.89% | 26.75% | -69.42% | 29/157 | 2.1% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 9.45% | 106.78% | 12.37% | 59/157 | 6.05% | 中哲精化 | 54.24% | 行业排名> |
| 2016-09-30 | 8.41% | -28.24% | 39.47% | 32/157 | 5.64% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 6.03% | -28.72% | 164.47% | 34/157 | 3.52% | ST南新 | 81.7% | 行业排名> |
| 2016-03-31 | 2.28% | -29.41% | -50.11% | 35/157 | 2.69% | 德展健康 | 29.5% | 行业排名> |